Cargando…
A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine
BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, fi...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200668/ https://www.ncbi.nlm.nih.gov/pubmed/17996045 http://dx.doi.org/10.1186/1860-5397-3-41 |
_version_ | 1782148297061826560 |
---|---|
author | Zheng, Jian-Feng Chen, Wen Huang, Su-Yu Ye, Jian-Liang Huang, Pei-Qiang |
author_facet | Zheng, Jian-Feng Chen, Wen Huang, Su-Yu Ye, Jian-Liang Huang, Pei-Qiang |
author_sort | Zheng, Jian-Feng |
collection | PubMed |
description | BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, filters, lenses of variable optical density, and photomechanical biomaterials etc. And (1R,8aS)-1-hydroxyindolizidine (3) has been postulated to be a biosynthetic precursor of hydroxylated indolizidines such as (+)-lentiginosine 1, (−)-2-epilentiginosine 2 and (−)-swainsonine, which are potentially useful antimetastasis drugs for the treatment of cancer. In continuation of a project aimed at the development of enantiomeric malimide-based synthetic methodology, we now report a divergent, concise and highly diastereoselective approach for the asymmetric syntheses of an aza-spiropyran derivative 7 and (1S,8aR)-1-hydroxyindolizidine (ent-3). RESULTS: The synthesis of aza-spiropyran 7 started from the Grignard addition of malimide 4. Treatment of the THP-protected 4-hydroxybutyl magnesium bromide with malimide 4 at −20°C afforded N,O-acetal 5a as an epimeric mixture in a combined yield of 89%. Subjection of the diastereomeric mixture of N,O-acetal 5a to acidic conditions for 0.5 h resulted in the formation of the desired functionalized aza-spiropyran 7 as a single diastereomer in quantitative yield. The stereochemistry of the aza-spiropyran 7 was determined by NOESY experiment. For the synthesis of ent-3, aza-spiropyran 7, or more conveniently, N,O-acetal 5a, was converted to lactam 6a under standard reductive dehydroxylation conditions in 78% or 77% yield. Reduction of lactam 6a with borane-dimethylsulfide provided pyrrolidine 8 in 95% yield. Compound 8 was then converted to 1-hydroxyindolizidine ent-3 via a four-step procedure, namely, N-debenzylation/O-mesylation/Boc-cleavage/cyclization, and O-debenzylation. Alternatively, amino alcohol 8 was mesylated and the resultant mesylate 12 was subjected to hydrogenolytic conditions, which gave (1S,8aR)-1-hydroxyindolizidine (ent-3) in 60% overall yield from 8. CONCLUSION: By the reaction of functionalized Grignard reagent with protected (S)-malimide, either aza-spiropyran or (1S,8aR)-1-hydroxyindolizidine skeleton could be constructed in a concise and selective manner. The results presented herein constitute an important extension of our malimide-based synthetic methodology. |
format | Text |
id | pubmed-2200668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-22006682008-01-16 A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine Zheng, Jian-Feng Chen, Wen Huang, Su-Yu Ye, Jian-Liang Huang, Pei-Qiang Beilstein J Org Chem Full Research Paper BACKGROUND: Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, filters, lenses of variable optical density, and photomechanical biomaterials etc. And (1R,8aS)-1-hydroxyindolizidine (3) has been postulated to be a biosynthetic precursor of hydroxylated indolizidines such as (+)-lentiginosine 1, (−)-2-epilentiginosine 2 and (−)-swainsonine, which are potentially useful antimetastasis drugs for the treatment of cancer. In continuation of a project aimed at the development of enantiomeric malimide-based synthetic methodology, we now report a divergent, concise and highly diastereoselective approach for the asymmetric syntheses of an aza-spiropyran derivative 7 and (1S,8aR)-1-hydroxyindolizidine (ent-3). RESULTS: The synthesis of aza-spiropyran 7 started from the Grignard addition of malimide 4. Treatment of the THP-protected 4-hydroxybutyl magnesium bromide with malimide 4 at −20°C afforded N,O-acetal 5a as an epimeric mixture in a combined yield of 89%. Subjection of the diastereomeric mixture of N,O-acetal 5a to acidic conditions for 0.5 h resulted in the formation of the desired functionalized aza-spiropyran 7 as a single diastereomer in quantitative yield. The stereochemistry of the aza-spiropyran 7 was determined by NOESY experiment. For the synthesis of ent-3, aza-spiropyran 7, or more conveniently, N,O-acetal 5a, was converted to lactam 6a under standard reductive dehydroxylation conditions in 78% or 77% yield. Reduction of lactam 6a with borane-dimethylsulfide provided pyrrolidine 8 in 95% yield. Compound 8 was then converted to 1-hydroxyindolizidine ent-3 via a four-step procedure, namely, N-debenzylation/O-mesylation/Boc-cleavage/cyclization, and O-debenzylation. Alternatively, amino alcohol 8 was mesylated and the resultant mesylate 12 was subjected to hydrogenolytic conditions, which gave (1S,8aR)-1-hydroxyindolizidine (ent-3) in 60% overall yield from 8. CONCLUSION: By the reaction of functionalized Grignard reagent with protected (S)-malimide, either aza-spiropyran or (1S,8aR)-1-hydroxyindolizidine skeleton could be constructed in a concise and selective manner. The results presented herein constitute an important extension of our malimide-based synthetic methodology. Beilstein-Institut 2007-11-08 /pmc/articles/PMC2200668/ /pubmed/17996045 http://dx.doi.org/10.1186/1860-5397-3-41 Text en Copyright © 2007, Zheng et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms) |
spellingShingle | Full Research Paper Zheng, Jian-Feng Chen, Wen Huang, Su-Yu Ye, Jian-Liang Huang, Pei-Qiang A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title | A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title_full | A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title_fullStr | A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title_full_unstemmed | A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title_short | A divergent asymmetric approach to aza-spiropyran derivative and (1S,8aR)-1-hydroxyindolizidine |
title_sort | divergent asymmetric approach to aza-spiropyran derivative and (1s,8ar)-1-hydroxyindolizidine |
topic | Full Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200668/ https://www.ncbi.nlm.nih.gov/pubmed/17996045 http://dx.doi.org/10.1186/1860-5397-3-41 |
work_keys_str_mv | AT zhengjianfeng adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT chenwen adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT huangsuyu adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT yejianliang adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT huangpeiqiang adivergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT zhengjianfeng divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT chenwen divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT huangsuyu divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT yejianliang divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine AT huangpeiqiang divergentasymmetricapproachtoazaspiropyranderivativeand1s8ar1hydroxyindolizidine |